AdvaMed®’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
Congress overwhelmingly approved the fifth Medical Device User Fee Amendment (MDUFA) agreement, helping to ensure new medical technology receives a more efficient FDA review to reach patients sooner if approved.
October is Breast Cancer Awareness Month and a good time to remember the importance of diagnostic screenings in saving lives.
CEO and surgeon Dr. Lishan Aklog speaks about the tremendous value of medical technology, the sharp disparities patients face, and the importance of policymaking to ease those disparities.
AdvaMed®’s Deputy General Counsel and Senior, VP of Legal, Pat Fogarty, joined Jack Kalavritinos, host of Capital Forum, and Jonathan Turner, Global Head of Compliance, Privacy and Governance, Zoll Medical,…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Mick Farrell, CEO of ResMed, joined Scott Whitaker on the Medtech POV podcast to explain what motivates him to serve patients and his community.
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed® developed tools and resources to…
Frans van Houten, CEO of Royal Philips, explains the potentially dire consequences of unchecked chip shortages for monitoring unborn babies, treating sudden cardiac arrest patients, assessing the vital signs of…
Pat Fogarty sat down with industry observer Jack Kalavritinos for a Q&A to discuss the current landscape of litigation in the medical device industry.
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
This document is intended to outline some of the potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.
Join over 500 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.